We are live on ! Find out more
ARTC

ARTHROCARE CORP
ARTC

Delisted

ARTC was delisted on the 29th of May, 2014.

117 hedge funds and large institutions have $1.05B invested in ARTHROCARE CORP in 2013 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 40 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

617% more call options, than puts

Call options by funds: $4.87M | Put options by funds: $680K

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

15% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 40

14% more capital invested

Capital invested by funds: $917M → $1.05B (+$133M)

1% less funds holding

Funds holding: 118117 (-1)

5% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 19

Holders
117
Holders Change
-1
Holders Change %
-0.85%
% of All Funds
3.39%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
18
Increased
46
Reduced
40
Closed
19
Calls
$4.87M
Puts
$680K
Net Calls
+$4.19M
Net Calls Change
+$4.24M
Name Holding Trade Value Shares
Change
Change in
Stake
GF
26
Gabelli Funds
New York
$9.05M
TA
27
Teachers Advisors
New York
$8.54M +$795K +21,450 +11%
BA
28
BlackRock Advisors
Delaware
$8.11M -$17.2M -465,192 -70%
TAM
29
Tiverton Asset Management
Delaware
$8.05M
Tudor Investment Corp
30
Tudor Investment Corp
Connecticut
$7.5M +$2.27M +61,395 +49%
TCIM
31
TIAA CREF Investment Management
New York
$7.35M -$127K -3,427 -2%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$7.22M -$2.63K -71 -0%
TC
33
TFS Capital
Pennsylvania
$7.04M +$922K +24,886 +17%
HW
34
Hancock Whitney
Mississippi
$6.92M +$442K +11,920 +7%
Fidelity Investments
35
Fidelity Investments
Massachusetts
$6.84M -$1.85M -50,000 -23%
BCM
36
Breithorn Capital Management
New York
$6.62M +$689K +18,600 +13%
Geode Capital Management
37
Geode Capital Management
Massachusetts
$6.58M +$1.32M +35,690 +28%
Wells Fargo
38
Wells Fargo
California
$6.5M +$5.95M +160,510 +14,447%
RFC
39
Russell Frank Company
Washington
$6.21M -$1.5M -40,490 -23%
Charles Schwab
40
Charles Schwab
California
$5.33M +$21K +568 +0.4%
AQR Capital Management
41
AQR Capital Management
Connecticut
$5.2M +$452K +12,200 +10%
BIM
42
BlackRock Investment Management
Delaware
$4.53M -$157K -4,231 -4%
Axa
43
Axa
France
$4.43M +$100K +2,699 +3%
Two Sigma Investments
44
Two Sigma Investments
New York
$4.36M +$1.62M +43,720 +68%
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$4.32M -$680K -18,343 -15%
Two Sigma Advisers
46
Two Sigma Advisers
New York
$4.2M +$871K +23,500 +29%
BNP Paribas Asset Management
47
BNP Paribas Asset Management
France
$4.05M +$79.4K +2,143 +2%
ECM
48
EII Capital Management
New York
$3.72M +$374K +10,100 +12%
JP Morgan Chase
49
JP Morgan Chase
New York
$3.59M -$1.33M -35,918 -29%
CII
50
CR Intrinsic Investors
Connecticut
$3.42M -$606K -16,368 -16%

ARTC Hedge Fund Activity: Q4 2013 in Review

117 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in ARTHROCARE CORP (ARTC) for Q4 2013, worth a combined $1.05B — up 14% from $917M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of ARTC and 18 opened new positions — a net loss of 1 holder — while 40 trimmed existing stakes and 46 added.

The largest buyer was Visium Asset Management, opening a new position worth an estimated $22.2M. The largest seller was BlackRock Advisors, cutting an estimated $17.2M.

  • 117 institutional investors held ARTHROCARE CORP (ARTC) as of Q4 2013, down from 118 in Q3 2013.
  • Funds reported $1.05B of ARTHROCARE CORP stock for Q4 2013, up 14% quarter-over-quarter.
  • 18 funds opened new ARTHROCARE CORP positions in Q4 2013 and 19 closed out, a net change of -1 holder.
  • The largest ARTHROCARE CORP buyer in Q4 2013 was Visium Asset Management, an estimated $22.2M added.
  • The largest ARTHROCARE CORP seller in Q4 2013 was BlackRock Advisors, an estimated $17.2M sold.

Based on aggregated 13F filings for Q4 2013.